Benzodiazepines for Anxiety Against a Patient's Own Addiction History
A single patient, three months into acute grief-related panic attacks. A benzodiazepine would likely help fast — but her own six years of hard-won recovery from alcohol use disorder makes that specific class of relief specifically risky for her.
C.B. is a 44-year-old accountant whose father died three months ago after a short illness. She has bipolar I disorder, stable on valproate for eight years, and a personal history of alcohol use disorder, in sustained remission for six years after a period in her early thirties she describes candidly as 'the closest I ever came to losing everything.' Since her father's death, she has developed escalating panic attacks — racing heart, chest tightness, a conviction she is about to die — occurring several times a week, severe enough that she has started avoiding driving on the highway and has missed four days of work this month. She is asking directly whether a benzodiazepine could help, because a coworker takes one for anxiety and has described real relief.
The clinical question here is not the generic caution sometimes raised about benzodiazepines in bipolar disorder as a population — it is specifically about her. She has her own documented history of alcohol use disorder, and benzodiazepines carry real cross-addiction potential for someone with that history, not a population-level statistic but a personal risk grounded in her own six years of hard-won recovery. Set against that is real, acute suffering: panic attacks severe enough to change her behavior and cost her paid work, arriving on top of grief she has not yet had much room to process. A fast-acting, effective anxiolytic is not a frivolous request from where she sits, even if it happens to be the class of drug that carries the most personal risk for her specifically.
Weighing acute relief against a personal addiction history
Her own history of alcohol use disorder is the central fact here, not a background detail to note and set aside. Benzodiazepines carry real cross-addiction potential for someone with a substance use history, and six years of remission, while genuinely hard-won, does not erase that vulnerability. I would not start one as a first step.
I don't think that fully closes the door, though. Her panic attacks are severe, acute, and clearly tied to a real precipitant, and a very short, tightly bounded course — days, not weeks, with an explicit stop date — is a different risk profile than open-ended maintenance use. I'm not proposing that as the first move, but I don't think it should be ruled out permanently either if the non-benzodiazepine approach doesn't work fast enough for her.
I take the addiction risk seriously. I just don't think "she has a substance use history" alone should be a categorical veto on every option in a class, the same way it wouldn't be for a patient needing acute pain control after surgery.
If a benzodiazepine is ever used with her, it needs to happen with her directly involved in that decision, not offered or withheld without her voice in it — she is the one who knows best what her own relapse risk actually feels like from the inside. My preference is to exhaust non-benzodiazepine options first and be honest with her about why, rather than a flat "no" without explanation.
Sertraline started at 25mg daily and titrating, alongside her unchanged valproate. Hydroxyzine offered for acute breakthrough panic in the interim. Referral made to grief-focused psychotherapy, and a follow-up scheduled in two weeks to reassess whether this approach is controlling her panic attacks adequately.
Whether a short, bounded benzodiazepine course would ever be appropriate for her was not resolved either way — the disagreement between prioritizing her addiction history categorically and treating her acute suffering as its own serious consideration was documented explicitly, with an agreement to revisit the question together with her if the current plan doesn't adequately control her symptoms.